China Approves First Commercial Brain Chip for Paralyzed Patients

What Happened Neuracle Medical Technology received regulatory approval to commercially sell its brain-computer interface (BCI) device designed to treat hand paralysis caused by spinal cord injuries. The implant detects brain signals when patients think about moving their hands, then translates these neural patterns through software to control an external robotic glove. This approval represents a significant regulatory milestone—while companies like Neuralink, Synchron, and European competitors continue conducting clinical trials, China has authorized the first BCI device for direct sale to patients and healthcare providers.